Form 4 Filing for Entrada Therapeutics, Inc.

This filing details the disposition of common stock by MPM BioVentures 2018, L.P. and its related entities in Entrada Therapeutics, Inc. (TRDA). On August 27, 2026, 38,922 shares were sold at a weighted average price of $7.20, with prices ranging from $6.88 to $7.37. On August 28, 2026, 3,733 shares were sold at a weighted average price of $7.01, with prices ranging from $6.95 to $7.24. On August 31, 2026, 44,259 shares were sold at a weighted average price of $6.99, with prices ranging from $6.76 to $7.1626. These transactions were executed by various entities under the MPM BioVentures umbrella, with MPM BioVentures 2018, L.P. holding a significant post-transaction share count of 4,231,434. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.